Medical News

RSS

Response Genetics enters agreement to settle SSF's proxy contest

Response Genetics, Inc. today announced that it has entered into an agreement with Special Situations Fund III QP, L.P., Special Situations Cayman Fund L.P, Special Situations Life Sciences Fund, L.P. and certain of their affiliates (collectively, "SSF") to settle SSF's proxy contest.

18 Sep 2010

Lawmakers debate action on stem cell research, public health bills

Sen. Arlen Specter said at a Senate hearing Thursday that Congress should move on allowing the government to fund human embryonic stem cell research "to avoid giving a final say on the issue to a conservative Supreme Court," The Associated Press reports.

18 Sep 2010

Penn study reveals structure of cell division's key molecule

On average, one hundred billion cells in the human body divide over the course of a day. Most of the time the body gets it right but sometimes, problems in cell replication can lead to abnormalities in chromosomes resulting in many types of disorders, from cancer to Down Syndrome.

18 Sep 2010

CBC members, patient advocacy organizations offer support for PRIME Act

In a presentation today at the Congressional Black Caucus Foundation's Annual Legislative Conference Health Braintrust meeting, Faina Shtern, M.D., president and CEO of AdMeTech Foundation, unveiled overwhelming support from Congressional Black Caucus members and patient advocacy organizations for the Prostate Research, Imaging, and Men's Education Act of 2010.

18 Sep 2010

APC gene mutation affects DNA methylation in colon cancer: Research

Colon cancer is the second most common cancer in the United States and causes more than 50,000 deaths each year. It has been known for some time that mutations in the APC gene occur in more than 85 percent of all sporadic colon cancers. Now researchers at Huntsman Cancer Institute at the University of Utah demonstrate in a study featured today in Cell the mechanism by which mutation of the APC gene affects a cellular process known as DNA methylation.

18 Sep 2010

FDA grants Optovue 510(k) clearance on Normative Database for RTVue OCT device

Optovue, the company that launched the first FDA cleared fourier/spectral domain OCT in the U.S., announced that it has received 510(k) clearance on its Normative Database ("NDB") for the RTVue OCT device.

18 Sep 2010

AdvanSource Biomaterials submits plan to NYSE Amex for compliance with listing standards

AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced it has submitted a plan advising the NYSE Amex of the actions it has taken and will take to bring the Company into compliance with certain listing standards of the NYSE Amex by February 17, 2012.

18 Sep 2010

Uninsured rate soars, 50+ million Americans without overage

Kaiser Health News staff writers Phil Galewitz and Andrew Villegas report: "In a reflection of the battered economy, the number of people without health insurance rose sharply last year to 50.7 million

18 Sep 2010

Arizona State University and Quintiles sign new drug development deal

Arizona's contribution to the accelerated development of new, safe and effective medicines to help treat suffering patients in the US and around the world, will become greater following the signing of new deal between Arizona State University and Quintiles (www.quintiles.com), a global integrated biopharmaceutical services company which is a leader in managing clinical research.

18 Sep 2010

Global Fund head repeats appeal for emerging countries to invest more in fight against AIDS, TB, malaria

Global Fund to Fight AIDS, Tuberculosis and Malaria Director Michel Kazatchkine on Thursday repeated his appeal for emerging countries to scale up their contributions to fight the three major diseases, Agence France-Presse reports.

18 Sep 2010

InVision-Plus connector reduces CLABSI infections: Report

The InVision-Plus needleless IV connector helped three different organizations sharply reduce and in some cases completely eliminate central line-associated bloodstream infections (CLABSI), according to three poster presentations that will be presented at AVA 2010, the annual scientific meeting of the Association for Vascular Access.

18 Sep 2010

Researchers awarded funds to assess effects of omega-3 fatty acids on breast cancer development

Two researchers at Marshall University have been awarded federal funds totaling more than $1 million to assess the effects of omega-3 fatty acids on breast cancer development.

18 Sep 2010

Opinions: Bachelet appointment; Sanitation MDG; Women's education; Smallholder farms

The appointment of former Chilean President Michelle Bachelet to head U.N. Women is an "excellent choice" that "adds stature and star power to the agenda for gender equality," according to a Los Angeles Times editorial.

18 Sep 2010

Atherotech Diagnostics publishes article on advantages of cholesterol testing

Detailed cholesterol testing for Type 2 diabetes patients is the focus of a newly published article by Atherotech Diagnostics Lab Chief Medical Officer Michael E. Cobble, M.D. The article discusses the clinical advantages of advanced cholesterol testing in reducing cardiovascular disease (CVD) risk in patients with Type 2 diabetes and details several currently available advanced lipid tests, including the VAP® Cholesterol Test from Atherotech.

18 Sep 2010

LCA receives Leadership in Advocacy Award

Lung Cancer Alliance received the Leadership in Advocacy Award at today's forum of the Congressional Black Caucus Health Braintrust in Washington D.C.

18 Sep 2010

EHS is now SuccessEHS

www.successehs.com, a Birmingham-based company specializing in physician practice management software systems and electronic health record (EHR) (sometimes called an electronic medical record or EMR), is pleased to announce they are changing their name, and the name of their flagship product CareRevolution™, to SuccessEHS™.

18 Sep 2010

Judge releases schedule for health overhaul lawsuit proceedings; Poll finds voters indifferent to candidates' reform positions

The federal judge overseeing a lawsuit brought by 20 states against health reform released a schedule this week that lays out how the case will proceed, The Hill's Healthwatch Blog reports.

18 Sep 2010

CMB initiates first human trial for plant-produced H1N1 influenza vaccine

Fraunhofer USA Center for Molecular Biotechnology (CMB) announced today it has initiated the first human trial of plant-produced H1N1 influenza vaccine at the Walter Reed Army Institute of Research Clinical Trials Center (WRAIR-CTC).

18 Sep 2010

Carter blames Ted Kennedy for delay in passing health bill

A decades old grudge between former president Jimmy Carter and the late senator Edward Kennedy was renewed again Thursday when Carter criticized Kennedy's stand on the former president's health care proposal. CBS "60 Minutes" quotes Carter as saying "that Kennedy delayed comprehensive coverage for Americans for decades.

18 Sep 2010

Ligand Pharmaceuticals transfers license rights to Proximagen for CXCR4 target

Ligand Pharmaceuticals Incorporated announced today that it has transferred exclusive license rights to Proximagen Limited for a series of compound hits related to the CXCR4 target with application for a number of indications including those related to the central nervous system. Ligand will receive an upfront payment and continue to be entitled to receive potential future milestone and royalty payments.

18 Sep 2010